SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/72E4A3B9BFB06B2DBA32472A36901C62BDF65D2D8E72D662D00C66A0B67D891245C63FD974DC092CCF87C2966770439D>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/72E4A3B9BFB06B2DBA32472A36901C62BDF65D2D8E72D662D00C66A0B67D891245C63FD974DC092CCF87C2966770439D
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/72E4A3B9BFB06B2DBA32472A36901C62BDF65D2D8E72D662D00C66A0B67D891245C63FD974DC092CCF87C2966770439D
http://www.w3.org/2000/01/rdf-schema#comment
"We demonstrated limited Eph/Ephrin expression; notably the only ligand highly expressed is EphrinB2 in Kaposi sarcoma"
xsd:string
http://purl.uniprot.org/uniprot/#_BFF291A8A0E7AA9D7D8AD3B8B5F8255702717CC6A0B80164F443DA19271A1593C7E3BC3EF97FC4055F555B5920E2084D
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/72E4A3B9BFB06B2DBA32472A36901C62BDF65D2D8E72D662D00C66A0B67D891245C63FD974DC092CCF87C2966770439D
http://purl.uniprot.org/uniprot/P52799
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/72E4A3B9BFB06B2DBA32472A36901C62BDF65D2D8E72D662D00C66A0B67D891245C63FD974DC092CCF87C2966770439D
http://purl.uniprot.org/uniprot/#_P52799-mappedCitation-18836096
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/72E4A3B9BFB06B2DBA32472A36901C62BDF65D2D8E72D662D00C66A0B67D891245C63FD974DC092CCF87C2966770439D